Liquidia Corp (LQDA)
12.79
-0.19
(-1.46%)
USD |
NASDAQ |
May 03, 16:00
12.78
0.00 (0.00%)
After-Hours: 20:00
Liquidia Stock Buybacks (Quarterly): -24.24M for Dec. 31, 2023
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -24.24M |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | -54.46M |
March 31, 2022 | |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | -21.71M |
March 31, 2021 | |
December 31, 2020 | 0.00 |
Date | Value |
---|---|
September 30, 2020 | -70.50M |
June 30, 2020 | 0.00 |
March 31, 2020 | -0.7254M |
December 31, 2019 | -31.17M |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.1748M |
March 31, 2019 | -32.05M |
December 31, 2018 | 0.0004M |
September 30, 2018 | -47.32M |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-70.50M
Minimum
Sep 2020
0.1748M
Maximum
Jun 2019
-12.66M
Average
--
Median
Sep 2019
Stock Buybacks (Quarterly) Benchmarks
United Therapeutics Corp | 1.00B |
AIM ImmunoTech Inc | -0.147M |
Perspective Therapeutics Inc | -0.364M |
Protalix BioTherapeutics Inc | 0.00 |
Armata Pharmaceuticals Inc | 0.00 |